- Notification that Annual Report will be submitted late (NT 10-K)

---

---

	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549    FORM 12b-25   NOTIFICATION OF LATE FILING	OMB APPROVAL
		OMB Number: 3235-0058
		Expires: November 30, 2012
		Estimated average burden hours per response ... 2.50
		SEC FILE NUMBER
		000-53665
		CUSIP NUMBER

 

(Check one):		x   Form 10-K o   Form 20-F o   Form 11-K o   Form 10-Q o   Form 10-D o   Form N-SAR o   Form N-CSR
		For Period Ended:	December 31, 2010
		o    Transition Report on Form 10-K
		o    Transition Report on Form 20-F
		o    Transition Report on Form 11-K
		o    Transition Report on Form 10-Q
		o    Transition Report on Form N-SAR
		For the Transition Period Ended:

 

Read Instruction (on back page) Before Preparing Form. Please Print or Type. Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

 

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

 

PART I — REGISTRANT INFORMATION

 

 

MEDICAL CARE TECHNOLOGIES INC.

---

Full Name of Registrant

 

 

---

Former Name if Applicable

 

 

Room 815, No. 2 Building Beixiaojie

---

Address of Principal Executive Office (Street and Number)

 

 

Dongzhimen Nei Beijing, China 10009

---

City, State and Zip Code

 

1

---

 

 

PART II — RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

 

ý

(a)

The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

x	(b)	The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F,11-K or Form N-SAR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and
o	(c)	The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

 

PART III — NARRATIVE

 

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, N-SAR, or the transition report portion thereof, could not be filed within the prescribed time period.

 

Registrant did not obtain all information prior to filing date and management could not complete Management's Discussion and Analysis of the year ended December 31, 2010 financial statements by March 31, 2011.

 

SEC 1344 (03-05)

Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

 (Attach extra Sheets if Needed)

 

PART IV — OTHER INFORMATION

(1)		Name and telephone number of person to contact in regard to this notification
Ning C. Wu				(8610)		6407 0580
(Name)				(Area Code)		(Telephone Number)

 

(2)		Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
		Yes  x      No  o

 

(3)		Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
		Yes  o      No  x
		If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

 

 

2

---

 

 

MEDICAL CARE TECHNOLOGIES INC.

 (Name of Registrant as Specified in Charter)

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

 
 

Date:		March 31, 2011		By:		/ s/ Ning C. Wu
						Ning C. Wu President, Principal Executive Officer

 

 

 

3

---